Transcript
0:16 Well, welcome everyone to another episode of AI and healthcare series sponsored by Stanford online. Um, and we are just absolutely thrilled to have our guest today, uh, Dr. Eric Toppel. Um, he really needs no introduction, but um, you may recognize him. He's the founder of Scripts Research Translational Institute and executive p vice president at Scripps Research. uh he's a major voice uh in AI genomics and precision medicine and a prolific author of uh deep medicine the patient will see you now and of course his new book super aers talking about longevity and we're going to talk a little about that today.
0:53 Uh he's also just generally an awesome uh colleague and friend and an advocate for tech enabled healthcare and I think has done a lot at least for me in my career I'm sure Justin you agree uh inspiring us to to really lean in and try to spread the word about the things that we know are happening in technology and how they may impact healthcare. So welcome Eric thanks for being here. Oh great to be with you uh Matt and Justin I know we'll have a fun conversation.
1:19 Well, well, one of the first things I I was curious about was h how do you do it all? H how how do you get all these pieces done? How do you write all that you do, speak all that you do? Um and you know, the context being uh there's this, you know, New Yorker article that came up recently of, you know, are are you just cheating your way through through college using AI from from a recent headline? Uh and we can talk about some of the educational pieces, but h how do you do it all? And we can talk about the education piece in a second. Uh well, it's kind of a combination of being two um things. One is being an infore, you know, just trying to ingest lots of information. And then the other being a lunatic. Um so yeah, I mean I don't have any secret. Um you can ask my wife of 46 years, she'll tell you that I'm a lunatic. So yeah, I well I mean but this is like have you I mean you've been doing this for you know a long time and again I feel like I've been you know following your work and and Justin and I you know we kind of try to bridge we try to stay up on you know healthcare and AI obviously in our in our day jobs but then it's also our I would say our passions as well. um when we see this technology kind of coming I I I keep you know running into evidence kind of what Justin was just showing.
2:39 Hey, this is really really good. This technology is really really good at uh you know tutoring you on a subject you know at your education, your grade level, whatever it is. Um I don't hear about folks using it for that much and I have to admit I've just started to um try to like you know have have a conversation with the model about maybe a new concept or a new paper. I I wasn't doing that as much and I I feel like I'm missing out um on some of the capabilities of the models to uplevel my own skill set and try to get my arms around all the all the new things that keep coming. I don't know. I don't know how you have approached this technology in your own personal work life, but it it seems like a lot of folks aren't really using it for that purpose. Yeah, I don't think uh people generally appreciate uh and even I'm sure a lot of your listeners um how um extraordinary capabilities are and it just keeps getting better like on a weekly whatever basis. It's just, you know, you want to do a generate a report on a a topic, you know, it could take weeks and here you have it in, you know, matter of minutes.
3:47 And you want to um you know tr in the case of um healthy aging and promoting uh the super aer story you know the the data uh across so many different layers at an individual level that no human would ever be able to assimilate. Uh but here you have uh models that will do that. So the capabilities are are just uh so powerful and I just keep getting blown away. I mean I you know first we all had the chat GPT moment in November 22. Um you know uh some months ago I started using um notebook LM and saw u you know podcast being generated you know from up to 50 PDFs you know to I mean what you know the the kinds of things you can do now are mindblowing and uh I don't think most people realize that because they just haven't you know been um you know testing it and more there's more awareness oh can fabulous relations and errors and propagation of biases and you know all sorts of things like that but not enough awareness of the of the of power I mean it's just beyond comprehension uh you know people talk about um you know have we achieved artificial super intelligence or AGI and you know I recently talked with Tyler Cowan who said look this is it I know porn when I've seen it this is it, you know, and I I mean, I don't know. It doesn't really matter what it is, but it's a lot. Well, we've had this discussion, Justin, in other episodes, too, about like the there's the cables are moving so quickly that it's uh I'm not sure I would I would know if we cross whatever line we're talking about for that moment of AGI and as like I mean, there's right it seems like there's just so much we can do with what's already here. And then when again when it comes to like interacting with the models in a you know education you know kind of way like this is the like what does this mean for like health healthcare as in general like how we train physicians and all the I don't think we've really um gotten our arms around this and I think you know as as folks are starting to use this in their you know high school and undergrad and uh what happens in med school like are we are we still really going back to sitting in classes and you know we all know the data on retention from live lectures and all this stuff. Are we are we really still going to do that or are we going to have to reinvent this? And I know you know you're involved uh but both Jess and I too in educating the next generation like I'm not sure how to incorporate this in to the curriculum.
6:32 Yeah, it's a great question. I you know I gave the commencement address at Mount Sina last week at their med school. Um so it made me think more you know with kind of the at the moment uh things are are so dynamic what what's it going to be uh for a medical school and I it's going to have to undergo some radical changes and you know the whole idea of memorizing stuff and um you know the the what would constitute the curriculum today is is already outdated terribly there's no AI in the curriculum which is amazing, right? I mean, wow. I mean, not that we want every, you know, physician to be a computer scientist, but they should at least feel very grounded, fil comfortable, understand the nuances and limitations. And there isn't a medical school yet today, which is embarrassing at 150 plus in this country that has really gotten this into their curriculum. So, a lot has to change there. Um, but also, you know, selecting who's going to be a doctor. um doesn't have to be the GPA and the MCAT score anymore. You know, we really want to get people who are um exuding the most human and humanistic qualities. So, uh we don't do that very well right now. We're we're not breeding people for their for those qualities as much as we need to in the future.
8:01 Where do you think we are, you know, in medical education or even healthcare more broadly? Because you have these conversations with leaders all across the country are invited to go speak with them. What do you think is the current understanding of the capabilities of the technology at at the leaders of healthcare across the country today? you know, do they obviously we're Matt and I are on and you are on one end of the spectrum of what we think this technology is doing and reading and keeping up, but where where is the average healthcare leader of a medical school as well as a you know health system today in your mind? I think it's the earliest phase. Um so you know it's being considered for you know back office operations for coding and things like that and operations but also you know maybe for trying to get uh the ambient conversations and reduction of keyboard and data clerk work for clinicians but it isn't farreaching at all. um it there isn't the interest of um getting patients empowered and charged to do more with their data. Uh there isn't really um you know widescale implementation. Um it's mainly in images related um and there isn't any multimodal AI that's really made its way through regulatory that's got into a health system at this point. So that's where everything is right now in terms of the excitement. um uh it's going to take a while. The problem I think that is driving the slowness which is characteristic of the medical community you know I've always thought of it's been sclerotic or oified right but what really is the lack of compelling data so I mean if we just go back to imaging which has several year history now you've got um studies of over 100,000 women in Sweden where randomized where The mammogram interpreted with a radiologist NAI was clearly superior picking up 25% more breast cancer and significant breast cancer and reducing the time. But what about the United States? How many what proportion of our mamograms are using AI with radiology readers as an example? How how long is it going to take with the most compelling data that we have to actualize it in daily practice? And you know, we have Radnet that's charging $35 to the women. I mean, this is crazy.
10:41 This should be routine. So, it isn't a good precursor to seeing what I'm envisioning, which is, you know, super aers and the future of health span. I do think we're going to get there, but it it takes much too long when the opportunities are so remarkably great. I well this and there's something to that right so like while we are and for probably a whole laundry list of reasons which we could go into but just why we're lagards and why a lot of this stuff has been challenging while that's going on consumers our patients have access to the literally the greatest AI technology on the planet on their phones or on their laptops and uh Justin you have that that quote from the there's now you There's anecdotal, you know, evidence everywhere where folks are putting in their medical data into the models on on their consumer, you know, on their consumer, you know, app and they're getting in some cases some pretty powerful results. And this is leading folks to say, well, now if the patient is able to to to use this powerful technology and and achieve, you know, a health outcome or or a diagnosis and they do that independent of the physician who decided not to use that or cannot use that. This was a a comment from of a malpractice attorney in an article. Very provocative thought.
12:03 But you know the position that he's he's he's kind of promoting here is that listen uh it's negligence if if you there's a tool that is better you know uh better for patient care if you could use it and you choose not to use it is you know I think that's a very this has never happened before to my knowledge like there was never like someone did such an amazing Google search that you know it it could it could you know make some you know really really powerful diagnosis that the physician may overlooked or that seemed much further away. But now we have literally a model that's going to, you know, reason over your healthcare data, find connections, and potentially, you know, give you a answer that, you know, maybe your clinician didn't couldn't do. Anyway, it just it's it's a fascinating every day. And um today um you know in the Wall Street Journal there was a a young fellow who wrote about how he was disabled and he used cloud uh anthropics um u prompting with all his data. He had all this sensor data and you know it it fixed him. I mean it's like wow after he had seen several specialists and whatnot. I mean it's a common story we're seeing now. Um and we're going to see a lot more of that. But you know unfortunately the medical system doesn't support um individuals to have more control. They want to control everything, right? They don't even want have all their data. I mean it's their data but they only can get a portal access and even that's limited, right? So um this is a real imbalance that shouldn't be tolerated.
13:46 uh but we we don't see enough of health systems that are p promoting AI in their patient base. Uh I mean another striking example is the first multimodal AI for patients uh besides um you know we go back to the diagnosis of arrhythmia through a smartwatch right but more recently the diagnosis of sudden death through a smartwatch FDA cleared uh it could save lives that if people are have that watch with an app and they they keel over and it brings the paramedics to their to them immediately. I mean that's amazing, right? So yeah, there's al and that's obviously a multimodal story of detecting pulselessness without you know and motionless and you know having a baseline. So um there's the opportunities here are just extraordinary. They're limitless and we need to give patients more charge.
14:45 They're eager to have it. It has to be you know practical, inexpensive, wellproven. It's easier to move the patient side than it is the clinical side. So, it's interesting you bring up that piece on consumer empowerment and consumers going to find this information. And it's interesting this week I'm actually out here in Washington DC right now where we've had a bunch of announcements um but relevant to this on you know an RFI um from CMS talking about wanting for more exchange of data wanting for more you know consumer uh access to that and then a real call for technology you know headedly in a way I haven't seen before from administrations coming in here. And so it seems like there's pressure on that side. The the other thing actually I'll pull up which was some interesting um examples of uh private companies starting to take a more aggressive view towards empowering consumers and I I was hoping to find uh more talk about this in your book but what's happening now of a kind of controversial within medicine of hey we're just going to scan healthy people and you know now using AI we can do it faster we can look for more as well as run tons of blood tests, combine AI on top of that, and uh it it's clear investors are super excited about this as a concept. Um and so, you know, with these companies combining to do all of this together, so how do you put how are you putting those pieces together? Well, it it is in my super aers book and it isn't good about doing fun a total body MRI. I can assure you. Um, this is a bad thing to have for healthy people because it's a recipe for false positives. And I've already seen patients who, for example, had a liver nodule, then they had a biopsy and they almost bled to death and or had a numoththorax from a chest nodule. All these are like benign things that are being found by total body MRI. And I just did a podcast with Mark Heyman who is the um you know co-founder of function and they just acquired Ezra the second largest purveyor of total body MRIs.
17:12 They reduce the cost and reduced the time. So what? It shouldn't be done. And I made it clear that none of these tests should be done unless there's a good reason that it's a person's risk. And finding a cancer in a mass on a scan is not as appealing as finding it at a microscopic level before it ever shows up on a scan. And we can do that in patients. So one of the three major age related diseases that I go through in super aers is cancer. We can get ahead of cancer. It takes 20 years for most cancers to fully take hold and get to a point of metastasis. Well, if we use a person's electronic health record, structured unstructured text, if we get set points of their labs, that is labs in the normal range but trending in the wrong direction that we can't see because we're just looking at normal or abnormal. And if you add to that um the cancer susceptibility genes, the pathogenic mutations, the gene whole genome sequence, the polygenetic risk score, uh and then things like a methylation clock, organ clocks, um you can get to the point I know this person's high risk for this type of cancer. And then you if that person irrespective of age you might get a um tumor DNA sample of the plasma so-called liquid biopsy and only then if the AI of that doesn't tell us where the organ is then you would get a total body MRI but right now everything is all screwed up.
18:52 You got promoting functional functions and many other companies are selling including particularly Pernovo uh selling uh total body MRI to to wealthy people for no with no data right and in the book I go through Drew Koular's case which he's a New Yorker writer and a great physician at Cornell and he goes along with getting a total free total body MRI. Guess what happens to him in his 40s? Healthy guy. They find a prostate abnormality. Now he has to get prostate biopsies every six months. That's a Don't sign me up for that. I'm sorry. Um yeah, his life is, you know, is completely been affected by that. And there's a great quote by a colleague uh in the book about it. Um look, this is terrible. This is predatory. Predatory. and we shouldn't let this happen. But it's unregulated jungle space. You know, it's great to have MRIs cheaper and quicker. Who wants to go hang out as a patient in an MRI machine? But use it for the right people. And it's just like mass screening for cancer. We have everybody treated like cattle, right? All the same. Just, you know, if you're a woman, you go for your mammogram. 88% of women will never have cancer. Why do we put all of them through this and have so many false positives and false negatives? So everything we do is so dumb and and wasteful and it just is way what it's doing. It's really good at is getting people um anxious for no reason.
20:38 And it's just we got to do better than this. you know, it's really I wrote a a long Substack on these 12 uh longevity quote longevity companies and there's not much there. You know, I do think they're on the right track that they want to get better data on people, but when they promote things with no proof, that's where I draw the line because we do have proof for a lot of things and we're not using it.
21:02 and and uh tell us tell us more about that side and I know and I know you got to see a bunch of really positive things. I love your synopsis of the book of lifestyle plus of areas of kind of it's it's great because I think we all have this conversations with family members, colleagues, friends. Hey, what what would you recommend for these things? It's a beautiful synopsis, I think, of what you said the highest quality evidence things, but talk to us just about a few of those and how you see AI playing a role in that in a in a positive way. Yeah. So, I mean, we don't get people to again here we are prescribing the same lifestyle for all people, you know, and not just diet, sleep, exercise, you know, you got many other layers of of that. That's why I called it lifestyle plus. Anyway, that doesn't work that well. You need to have that at an individual level and who's likely to adopt these things. It's people who know they're at risk, right?
22:03 And they're at risk, you know, way in advance. And we have this opportunity we've never had before for primary prevention. I mean, this has been a fantasy for millennia in medicine that we would prevent diseases from ever occurring. We don't do that today, but we can now. Lifestyle is a big way to do it. uh and that is think I think once we get into this that you accept that there's these three age related diseases not that we're trying to reverse aging we're we're we're accepting aging we just want to pres prevent the diseases that are pegged to aging process very different lean uh you know different position any rate so once you have these three then the lifestyle factors are common for all you exercise, you know, is as essential, paramount, if not if there's one thing um and it's not just aerobic, it's, you know, resistance and strength and and um balance. I mean, all these things are critical as we get older. The diet is, you know, very important not to have a pro-inflammatory diet. Ultrarocessed food, lots of red meat, things that we know are not good for you for for that.
23:20 Um, and then of course sleep, getting deep sleep when we clear these uh waste products from our brain that are just bad. We got to get them out of there. We need more deep sleep as we get older. and we can track it now easily uh with a smartwatch with a ring and you know pretty accurately. So those are some fundamentals. There's many other layers but once you know you're at risk for let's say Alzheimer's 20 years in advance and you know things can help and you get a PTA 217 biomark which is would be abnormal 20 years in advance. That's what's amazing. And it responds to exercise and lifestyle. And you can bring it down 40, 50, 70%. You're motivated now. You can see your lifestyle kicking in just like you would LDL cholesterol with a statin. So this is what makes these three diseases. And each has their own strategy like I mentioned PTA 217 and other neuro uh inflammation markers, right? Um, this is a unique time in medicine. We've never had this. We had to have the AI to integrate all the data and we had to have the organ clocks and these biomarkers and, you know, liquid biopsies and all these things. We didn't have those until, you know, recent times, some very recent time. That's why we're so set up right now. It's a convergence of the science of aging with the advances in large language models and large reasoning models.
24:53 Yeah, I this is this is so spot on. I think um how AI is kind of coming in at the right time in a lot of different ways, but but for this in particular, it's kind of again ties back to what we were saying about consumer empowerment, but it's not just about, hey, uh let's throw you in as many, you know, scans as possible and it's collecting the right data. It's addressing some of the things that we know are evidence-based that are, you know, leading to chronic disease. um and you know tied to healthy aging those behaviors. But there's also an aspect of this too that that you also mentioned which um I I'm just seeing a lot more I I feel maybe it's just you know confirmation bias. I I feel like there's a lot more interest when you hear about AI drug discovery and identifying you know ways to now address some of these age related processes. Now again, I'm not saying there's the fountain of youth in a pill, although I'm sure there's startups that will be pitching that. But there is some aspect of this that now that we have a better understanding of the surface area of the things that we know are like definite contributors to disease, are we now able to look at the therapeutic side? And does AI also help us there? and and and again this is it my crystal ball is a little foggy in this space but it does seem like with this rapid ability to to identify targets and identify functions um and now that we're pointing it at things that are related to longevity talk about that a little bit because I know that you touch on this in your book and um it's it's just an area that I I don't know if I understand well enough and I haven't seen um I guess the the the sort of breakthrough that I that maybe I would expect Yeah, I think it's coming. I mean, I think the ability to uh identify targets and project their uh efficacy and safety profile, I mean, that's all going to accelerate. There aren't that many great examples yet, but I think we'll see them. um and even you know not just predicting protein structure 3D at high resolution but uh designing the proteins and and small molecules and antibodies and the the you know all the biomolecules so that's in the works but what I think is something to get some perspective is the GLP-1 drugs all right so this a whole chapter on that and If if we if we would go back 20 years ago when they the um uh no nova noris only wanted to develop this for diabetes and if they had asked AI should we just should we look at it for obesity you know I quipped in the book yeah they should the AI would have told them but it took uh a a human to keep pressing them there in Denmark lot newen for years we got to try this obesity, you got to try it. And it's amazing because, you know, the reason they didn't want to do it is because the di people with diabetes didn't lose any weight, like three or four pounds. People with obesity lost 40, 50, 80 pounds. We still don't know why. And you I even asked a AI why, and it didn't give me an answer, right? Nobody knows why. There's theories, right? There's lots of theories like why do women live longer than men? Nobody knows that either really. At any rate, um you know this is uh we are in a time when all these gut hormones we're just getting started. Now if you think that these drugs are you know miracle drugs like you know Zmpic and Zeppbound and Marjaro you you ain't seen nothing yet. We got triple receptors, we got pills and we got a lot more gut hormones coming you know. Uh any rate the gut hormones talk to the brain. They talk to our immune system.
28:49 They're potent. They're well tolerated. We don't know any serious side effects really when you think about it. We're This is going to explode. And that's just talking about gut hormones, right? Yeah. So, no, we're we just if you you guys are young, but we've been trying to crack this obesity case for, you know, a long time, you know, a long time. Many decades, right? And now look at this. I mean, it's just we got people taking these drugs just to lose, you know, five pounds to whatever. It's ridiculous, but it's amazing what's happening here. Uh, and I don't want it to continue in terms of a drug, you know, a forever drug. I'd like to see people take advantage of this and, you know, get off of them and be very inexpensive and get keep getting better. But that should tell you we're in a new age of, you know, drug discovery itself. just one class of drugs and it's broad. I'm not just talking about glucagon like peptide or glucagon. I'm talking about all the gut hormones because there's a lot of them.
29:51 When I was in medical school, there weren't any gut hormones instrumentation, you know. Now there's like 50 of them. Yeah. Well, well, what there's there's almost too much to cover on kind of what's coming next and down the pipe like today today if you know a lot of you know I think think our audience is trying to figure this out for themselves. How do they use the tools? Where do they do this? So like today today you know what are you using? What would be a message you would want people to take away for where they should be experimenting or using some of these tools now? Well, I mean, I'll use anything as long as it works, as long as it helps me. Um, so I don't know that there's, you know, getting into nitty-gritty helpful there. But I I just would go back that, um, you know, when the when you I think only in a tunnel vision of how can I use AI to improve health. That's what I that's what I think about. I'm obsessed with it. I I've been obsessed with it for many years and I don't know if I'll ever get over it. Right. Um so that's what I think about and that's why I think the next frontier is prevention. You know, Demis Habis was on 60 Minutes a couple weeks ago and uh he said, you know, well, end of diseases, cure diseases within the next decade. I don't see why not, he said. Um, and you know, a lot of people don't think that's possible, and I don't think it's going to happen in 10 years, but we have a way forward now to use these tools and to keep improving them so that we can really get there.
31:34 And that's why we're going to have a lot more people right now, they're the few than the elderly people, which are the almost all after age 60some. We can flip that and it's really exciting. And so that's that's what I keep thinking about and that's what I'm working towards and that's what the book Super Agers is all about. And I I feel like you know uh your your obsession we benefit from your whether you whether you think it's healthy or not your your obsession with health and I because honestly it's it's it's laid out so clearly here in the in that framework. Um and and again in terms of using the different tools, I think part of it is just the fact that you you know that you encourage that folks do that.
32:18 Like I think it's important because of the accelerating pace of it's still that jagged edge, right? Like there's still things that hey, it's not quite there in this one or two, you know, one or two areas, but yet it's so profoundly good in others. And if you but without that intuition it becomes hard maybe to even see where that how that vision plays out. Um I know you know Justin you have that there's a there's a there's a a graphic where it's sort of like what are folks starting to converge on using these models for in their day-to-day life. And it started out with like hey can you answer this quick question? Can you you know you know write this blog?
32:58 And now look at this. This I mean this to me is fascinating and this this ties into another theme in your book super interest to me because you you see again it's edit editing text generating ideas and this little number two category therapy and companionship from 2024 now was the number one use and then we have organizing my life and then we have finding purpose. It's this is this like sort of starting to address the idea of social isolation and loneliness as a contributor to a decline in health and wellness and and and is this again another place where unexpectedly something is coming up from the technology side to fill that gap or to fill that need and anyway the point is I feel like folks are starting to tell us what these models are more useful for to them in their daily lives and it's surprising to me that it's not homework and uh you know doing my TPS reports at work, right? It's it's these are things that I wouldn't have predicted u having been in technology for this long that that would be so popular. Well, I mean you're absolutely right, man. And when I wrote deep medicine, I wrote that the machines will never help with empathy. I couldn't have been more wrong, right?
34:13 Because now there's like 12 studies to show that patients perceive empathy from machines more better than the their doctors. I mean what how could this be? U now uh that's of course doctors are rushed and um and machines don't even know what empathy is but they can transmit it. They can be a vector for it just from having learned been pre pre-trained with language. So what we're seeing is something I never would have predicted. Um and it's rep replicated many many times through various different studies. Right? So I'm I know there's something there. Uh it also tells us that we we humans have to amp it up if we can be beaten so easily as physicians by machines. Right. So um you know it's exciting that the unpredictable positive features that you touched on. Uh and and it it it isn't like we're plateauing here. Uh you know, we're going to keep seeing progression capabilities. And uh yeah, here's another graph of yours. Yeah. And you you just brought this up and it's come up a bunch of times, but I think what I certainly didn't predict was that for much longer I thought AI plus human performance would beat out AI on some of these diagnostic tasks. And this was another actually Matt, do you want to give some more context on this benchmark from OpenAI this week on their evaluation set showing again actually these models now can start to perform better without humans uh tweaking.
35:46 Yeah, this is this is uh it's called Healthbench uh was released by OpenAI, right? A nice in a nice contribution if I'm being honest to the broader community because it is open source data set. uh five plus thousand conversations, a couple hundred physicians on simulated medical questions from 60 countries almost I think it's around 50 languages and across you know dozens and dozens of medical specialties and then they do these really full evaluations and and again it's I think it's meant to be sort of a a nice new thing for the for the community to think about as they evaluate the medical performance of these models as opposed to stuff listen I step one was hard and I am impressed that these models do well but but as we've saturated those benchmarks we I think we all recognize that maybe that's not the ultimate goal of of you know leveraging these models to do medical type tasks and so this one I think is slightly more realistic I would say some of the great work that Nigum Shaw's group has done at Stanford in Med Helm another way to sort of to take real world medical data and turn those into benchmarks and then be able to rate and rank the different models but just Another example though where I I I think part of this is just not I I still hold out faith despite you know being you know accused of being on the vode side of the spectrum on some of this. I still believe that physicians with these tools if we can figure out how that relationship is ultimately symbiotic in a good way. I think we're it's going to be awesome. But right now, it still feels like we're kind of at that junior high dance where doctors are on one side, EI on the other a little bit. We haven't figured out how to dance together um to to make the kind of results that we expect to see, which is together that they're better. Yeah, it's a good metaphor with the dancing um and junior high. But no, uh, you probably know Prenav, who you know very well, Rush Burker and I, wrote an op-ed in the New York Times when we commented on six studies where AI was compared to doctors who had AI and and whether it was radiology or whether it was diagnosis or patient management, all six studies showed the AI better in performance and that was not anticipated as you said that there was no symbiosis there now.
38:05 Is that because doctors are not grounded with AI even though they had it to be able to use? Is it because they have automation um bias that they just don't don't appreciate it can help? Or is it because the studies are contrived? They're not like real world medicine. We don't know yet. I hope like you just asserted uh or uh pined that we're going to get there that we will get the best of both worlds but we don't have evidence for that yet and it looks like I hadn't seen that graph from uh the benchmark that open AAI just um released yesterday I think or a couple days ago but yeah I mean it's the same kind of thing um right right now we don't have evidence that that uh best of both worlds is is working. We we we have AI um exceeding the performance, which hopefully that's not going to be the way it rolls out. Prrenav thinks it will, just so you know. So, he and I have all these discussions. Of course, he's a computer scientist and I'm a physician, so we we go at it. And um I don't know who's going to be right here, but he he still thinks the AI is going to win no matter what. We'll see. Well, he's much smarter than I am. I can say that. I've worked with him for years. Um, but you know, I'm a I'm an irrational optimist.
39:26 I I think there's got to be some secret sauce of of us being able to leverage these things to really take it all to the next level. But, uh, but I I'll remain optimistic until hopefully some evidence backs me up a little bit on that. So, I'm I'm with you, just so you know, I'm I'm very much with you. And and a lot of people forget who don't come from medicine. you know, many of our patient visits start when you already have the diagnosis set and there are guidelines that even get you to the right treatment. So like often that is the starting point and I think a lot of people outside of medicine go oh the job is done if I have the diagnosis and you know often that's the the starting point and so anyway it will be fascinating to to see to see how this evolves.
40:09 Well, thanks for another awesome conversation, uh, Eric. Thanks for joining us. Um, this was tremendous. Um, I do encourage everyone to please pick up the book Super Agers. You won't be disappointed. There's some there's some pretty big insights in there that I think that, uh, are starting to touch on a theme that we're I think we're going to see a lot more of in the future, which is, uh, aging. Well, I like your I liked your term, welderly, uh, because we're all we're all going to get there someday soon. Um, and in my case, more sooner than some others. But I I do feel like understanding really where uh the truth lies amongst all the hype and the swirling I think is is critical here and and and how AI is going to take us to that next stage. No, thanks. Great to be with you both.
Summary
- AI's capabilities are rapidly evolving, offering extraordinary tools for data analysis and patient empowerment.
- Medical education must incorporate AI to prepare future physicians for its integration into healthcare.
- Current healthcare leaders are slow to adopt AI, primarily using it for back-office tasks rather than patient care.
- Consumer access to AI tools is growing, leading to potential disparities between patient-driven insights and traditional medical practices.
- The use of total body MRIs for healthy individuals can lead to unnecessary anxiety and medical interventions.
- Lifestyle changes, informed by AI, can significantly reduce the risk of age-related diseases.
- AI is beginning to show promise in drug discovery and understanding complex biological processes.
- The relationship between AI and healthcare professionals is still evolving, with current studies showing AI often outperforms doctors without their assistance.